Skip to main navigation
Skip to search
Skip to main content
Ben-Gurion University Research Portal Home
Help & FAQ
Home
Profiles
Research output
Research units
Prizes
Press/Media
Student theses
Activities
Research Labs / Equipment
Datasets
Projects
Search by expertise, name or affiliation
A placebo-controlled cross-over trial of adjunctive EPA in OCD
M. Fux, J. Benjamin, B. Nemets
Research output
:
Contribution to journal
›
Article
›
peer-review
80
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'A placebo-controlled cross-over trial of adjunctive EPA in OCD'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Obsessive-compulsive Disorder
100%
Placebo-controlled
100%
Eicosapentaenoic Acid
100%
Controlled Crosses
100%
Placebo
50%
Hamilton Depression Rating Scale (HAM-D)
33%
Yale-Brown Obsessive-Compulsive Scale (Y-BOCS)
33%
Clinically Significant
16%
Beneficial Effects
16%
Antidepressants
16%
Treatment-resistant Depression
16%
Maximum Tolerated Dose
16%
Omega-3 Fatty Acids
16%
Hamas
16%
Major Affective Disorders
16%
Liquid Paraffin
16%
Pharmacology, Toxicology and Pharmaceutical Science
Icosapentaenoic Acid
100%
Placebo
100%
Obsessive Compulsive Disorder
100%
Selective Serotonin Reuptake Inhibitor
33%
Clinical Study
16%
Omega-3 Fatty Acid
16%
Antidepressant
16%
Side Effect
16%
Maximum Tolerated Dose
16%
Liquid Paraffin
16%
Major Affective Disorder
16%
Neuroscience
Icosapentaenoic Acid
100%
Placebo
100%
Obsessive-Compulsive Disorder
100%
Selective Serotonin Reuptake Inhibitor
33%
Omega 3 Fatty Acid
16%
Antidepressant
16%
Hamilton Rating Scale for Depression
16%
Major Affective Disorder
16%